ARCHIVES

Source Identified for Hepatitis A Contamination of LAK-IL-2 Trials; Six MIs Seen; Rosenberg Updates Intramural Results

This article is from The Cancer Letter archive.

Vol. 12 No. 41 | October 24, 1986

Download PDF Visit The Full Archive

Related Articles

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990

Letter: Boy Has Little Chance At Cure Without Proven Treatments.

February 11, 2000

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003

In Brief: NVI Delays Release Of Laetrile Study Result; DCCRC’s New Name: Div. Of Extramural Affairs

August 25, 1978